Gravity Diagnostics Announces Partnership with the Cincinnati Reds Under Its New Consumer Health Company, Gravity+
April 05, 2022 10:39 ET
|
Gravity Diagnostics
Covington, KY, April 05, 2022 (GLOBE NEWSWIRE) -- Gravity Diagnostics, recently named Greater Cincinnati's fastest-growing company, proudly announces the official sponsorship of the Cincinnati Reds...
Inagene Diagnostics Inc. provides personalized medicine with genetic guidance to medical cannabis users
November 18, 2021 06:00 ET
|
Inagene Diagnostics Inc.
TORONTO, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Since cannabis legalization in 2018, interest in its medical application has been skyrocketing. Canadian consumers and health care providers seek guidance...
Inagene Diagnostics Inc. and The Newly Institute partner to optimize treatment for Canadians living with pain and/or mental health conditions
November 16, 2021 06:00 ET
|
Inagene Diagnostics Inc.
TORONTO, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Canadian pharmacogenetic (PGx) testing provider, Inagene Diagnostics Inc., has partnered with The Newly Institute, an advanced network of medically...
Inagene Diagnostics Inc.’s CEO featured alongside global expert advocates highlighting pharmacogenomic (gene-drug compatibility) testing as a game-changing innovation to safeguard the health of Canadians
November 09, 2021 06:00 ET
|
Inagene Diagnostics Inc.
TORONTO, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Focused on The Future of Innovation, Personalized Medicine and Genomics, the 21st Annual Healthcare Summit brought together global healthcare experts,...
Inagene Diagnostics Inc. and Granville Biomedical Inc. team up to provide locally-produced pharmacogenetic testing kits to Canadians
November 01, 2021 06:00 ET
|
Inagene Diagnostics Inc.
TORONTO, Nov. 01, 2021 (GLOBE NEWSWIRE) -- Canadian pharmacogenetic (PGx) testing provider, Inagene Diagnostics Inc., has partnered with fellow Canadian health-tech company, Granville Biomedical...
Drug-gene compatibility testing should be considered an essential standard of care in long-term care and retirement communities
October 01, 2021 06:00 ET
|
Inagene Diagnostics Inc.
TORONTO, Oct. 01, 2021 (GLOBE NEWSWIRE) -- The past year has highlighted the vulnerability of our seniors and the need to evaluate opportunities to better safeguard their health, especially those...
September’s International Pain Awareness Month marks critical moment to leverage more effective methods of treating chronic pain
August 26, 2021 06:00 ET
|
Inagene Diagnostics Inc.
TORONTO, Aug. 26, 2021 (GLOBE NEWSWIRE) -- September marks Canada’s most important International Pain Awareness Month yet. The stressors brought on by the COVID-19 pandemic have manifested as new...
Inagene and Aspiria team up to improve mental health care for post-secondary students
August 16, 2021 06:00 ET
|
Inagene Diagnostics Inc.
TORONTO, Aug. 16, 2021 (GLOBE NEWSWIRE) -- Canadian pharmacogenetic (PGx) testing provider, Inagene Diagnostics Inc., has partnered with Student Assistance Program provider Aspiria Corp., a CloudMD...
Canada’s surgery backlog could lead to wave of new chronic pain and opioid dependencies
July 21, 2021 06:00 ET
|
Inagene Diagnostics Inc.
TORONTO, July 21, 2021 (GLOBE NEWSWIRE) -- As Canada’s vaccination rates climb and hospitals begin to tackle the mountain of postponed surgeries due to the pandemic, we are facing an echo epidemic...
Canadians living with mental health conditions stand to save over $57 billion with use of pharmacogenetic testing
June 08, 2021 07:00 ET
|
Inagene Diagnostics Inc.
TORONTO, June 08, 2021 (GLOBE NEWSWIRE) -- Inagene Diagnostic Inc., a Canadian pharmacogenetic testing company, and Calian Group Ltd., one of Canada's largest national health services organizations,...